BioMérieux Announces Upcoming Launch of VIDAS Anti-SARS-CoV-2 Serology Tests
BioMérieux (Marcy-l'Étoile, France) has announced performance validation and the upcoming launch of VIDAS anti-SARS-CoV-2 serology tests to detect antibodies in people who have been exposed to the SARS-CoV-2 that causes the COVID-19 disease. More...09 May 2020
Gilead’s Remdesivir Granted Regulatory Approval in Japan for Patients with Severe COVID-19
The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted regulatory approval to Veklury (remdesivir) as treatment for SARS-CoV-2 infection under an exceptional approval pathway. More...09 May 2020
IDEXX-Made OPTI SARS-CoV-2 RNA PCR Test Kit Secures FDA Emergency Use Authorization
IDEXX Laboratories, Inc.’s (Westbrook, ME, USA) subsidiary, OPTI Medical Systems, Inc. (Roswell, GA, USA), has been granted Emergency Use Authorization (EUA) by the US FDA for its OPTI SARS-CoV-2 RT-PCR laboratory test kit for the detection of SARS-CoV-2. More...08 May 2020
Sherlock CRISPR SARS-CoV-2 Kit Becomes First FDA-Authorized Use of CRISPR Technology for COVID-19
Sherlock Biosciences (Cambridge, MA, USA) has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its Sherlock CRISPR SARS-CoV-2 kit for the detection of the virus that causes COVID-19, providing results in approximately one hour. More...08 May 2020
Moderna Receives FDA Clearance for Phase 2 Study of mRNA-1273 Novel Coronavirus Vaccine
Moderna, Inc. (Cambridge, MA, USA) is making progress on its novel coronavirus vaccine (mRNA-1273) and has received clearance from the US Food and Drug Administration (FDA) to proceed with its Phase 2 study. More...08 May 2020
New
Gold Member
X-Ray QA Meter
T3 AD Pro
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Mobile Power Procedure Chair
LeMans P360
New
Transcatheter Heart Valve
SAPIEN 3 Ultra
In Other News
Hardy Diagnostics’ COVID-19 Antibody Test Granted FDA Emergency Use Authorization
Eurofins Launches CE-IVD Marked Multiplex Real-Time PCR Assay for SARS-CoV-2 Detection
Self-Sanitizing Face Mask Could Potentially Slow Spread of Novel Coronavirus
Machine Model Exponentially Shortens Expert Review Period for COVID-19 Treatments and Vaccines
Injectable Antibiotic with New Mode of Action Could Significantly Impact COVID-19 Morbidity Rate
Siemens' Fast Track Diagnostics SARS-CoV-2 Test Granted FDA Emergency Use Authorization
Coronavirus SARS-CoV-2 Infects Human Intestinal Cells, Finds Study
Revolutionary New Carbon-Based Material Captures and Destroys Coronavirus
World’s First Wearable Device Continuously Tracks Key Symptoms of COVID-19
FDA’s Revised Policy Tightens Requirements for COVID-19 Antibody Tests
Researchers Achieve Significant Breakthrough in Extracting Key Antibodies to Neutralize Coronavirus
Scientists Develop Anti-Coronavirus Surface Coating Based on Nanomaterials
Pfizer and BioNTech Dose First US Participants for BNT162 COVID-19 Vaccine Program
PerkinElmer Secures FDA Emergency Use Authorization for EUROIMMUN’s Anti-SARS-CoV-2 ELISA Serology Test
Italian COVID-19 Vaccine Becomes First to Neutralize Coronavirus in Human Cells
Fluke Begins Producing Plastic Industrial Face Shields and Shares Design Specs
PlexBio Receives CE Mark for PCR-based Coronavirus Detection Kit
BioMérieux's BioFire SARS-CoV-2 Respiratory Panel Obtains FDA Emergency Use Authorization
Bio-Rad ddPCR COVID-19 Assay Secures FDA Emergency Use Authorization
Roche’s COVID-19 Antibody Test Receives FDA Emergency Use Authorization
Researchers Discover Antibody that Blocks Novel Coronavirus SARS-CoV-2 Infection in Cells
Researcher Claims COVID-19 Damages Hemoglobin and Hydroxychloroquine Promises Coronavirus Immunity
Quotient Limited Receives CE Mark for Its SARS-CoV-2 (COVID-19) Antibody Microarray
